NCT01753323View on ClinicalTrials.gov

Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Malaria
Interventions
DRUG

KAF156

KAF156 was supplied as tablets for oral use.

Trial Locations (5)

10000

Novartis Investigative Site, Hanoi

10400

Novartis Investigative Site, Bangkok

33140

Novartis Investigative Site, Si Sa Ket

63110

Novartis Investigative Site, Tak

63140

Novartis Investigative Site, Tak

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY